Company Introduction

AMOLIFESCIENCE has been doing its best to supply our products and services that customers need in the fields of bio, diagnostics and healthcare since its establishment in 2016 as a member of AMO Group.
We are striving to enhance the convenience of our customers by developing value-added materials and applications required by the market based on the state-of-the-art nano and new material technologies applied to magnetic nanoparticles (AMO-Mag) and nano membrane (AMO-Fiber) products.

Amolifescience has developed AMO-MAG® for more than a decade to achieve the performance required for bio and life science applications. It has been intensively developed to satisfy the most fundamental superparamagnetism, fast response performance, uniformity, and high efficiency.

Since 2004, AMO Group has been developing and manufacturing electro-spun nanofibers. AMO Group possesses 283 patents, the most nanofiber-related patents in the world.
AMO specializes in multilayered structures with customized surfaces and additives. Its mechanical structure and the human extracellular matrix (ECM) are highly comparable, making it an ideal biomedical use. It is transparent and extremely thin, but as elastic as skin. AMO currently provides western blot, a synthetic microenvironment for cell culture, and wound dressing made by these materials.

AMO bioreactor provides a scalable manufacturing platform with monitoring and control of critical quality attributes as single use for various cell culturing
AMO Bioreactor provides a predefined microenvironment comparable to ECM with a "Webtrix" peptide motif-coated membrane surface. The Webtrix technology can provide both a manual version as a plate and an automatically integrated system as a bioreactor. Webtrix technology can be coated with a fibronectin-derived peptide to promote cell attachment and proliferation.